|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-1-18
|
|
pubmed:abstractText |
We compared the laboratory and clinical findings of 179 patients with essential thrombocythemia (ET) and 77 with polycythemia vera (PV) classified according to the presence of the JAK2 V617F mutation. A gradient was observed in laboratory values between patients with JAK2 wild-type ET, JAK2 V617F ET and PV (all of whom carried the JAK2 mutation). The rate of thrombotic complications in JAK2-positive ET patients was significantly higher than that in wild-type ET patients and not statistically different from that in PV patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1592-8721
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
92
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
135-6
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17229651-Adolescent,
pubmed-meshheading:17229651-Adult,
pubmed-meshheading:17229651-Aged,
pubmed-meshheading:17229651-Aged, 80 and over,
pubmed-meshheading:17229651-Child,
pubmed-meshheading:17229651-Female,
pubmed-meshheading:17229651-Humans,
pubmed-meshheading:17229651-Janus Kinase 2,
pubmed-meshheading:17229651-Male,
pubmed-meshheading:17229651-Middle Aged,
pubmed-meshheading:17229651-Mutation,
pubmed-meshheading:17229651-Polycythemia Vera,
pubmed-meshheading:17229651-Risk,
pubmed-meshheading:17229651-Thrombocytopenia,
pubmed-meshheading:17229651-Thrombosis
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status.
|
|
pubmed:publicationType |
Letter
|
